Advertisement

Milrinone Injection

[19 May 2015]

Products Affected - Description

Milrinone injection, Fresenius Kabi 
1 mg/mL, 20 mL vial, 10 count (NDC 63323-0617-20)
1 mg/mL, 50 mL vial, single count (NDC 63323-0617-50)
 
Milrinone injection, West-Ward
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00143-9719-10)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00143-9718-10)
1 mg/mL, 10 mL vial, 10 count (NDC 00143-9710-10)
1 mg/mL, 50 mL vial, single count (NDC 00143-9708-01)

Reason for the Shortage

  • Fresenius Kabi states the reason for the shortage is increased demand for the product.
  • West-Ward states the shortage is due to manufacturing delays.
  • Ben Venue stopped production in its plant in Bedford, Ohio and closed in July 2014.
  • Apotex, Bioniche, and Teva discontinued milrinone 1 mg/mL vials.
  • Sanofi-Aventis discontinued Primacor injection.

Available Products

Milrinone injection, Baxter
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00338-6010-48)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00338-6011-37)
 
Milrinone injection, Fresenius Kabi
1 mg/mL, 10 mL vial, 10 count (NDC 63323-0617-10)
 
Milrinone injection, Hospira
1 mg/mL, 10 mL vial, 10 count (NDC 00409-0212-01)
1 mg/mL, 20 mL vial, 10 count (NDC 00409-0212-02)
1 mg/mL, 10 mL vial, single count (NDC 00409-0212-03)
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00409-2776-23)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00409-2776-02)
 
Milrinone injection, West-Ward
1 mg/mL, 20 mL vial, 10 count (NDC 00143-9709-10)

Estimated Resupply Dates

  • Fresenius Kabi has milrinone 1 mg/mL 20 mL and 50 mL vials on back order and the company cannot estimate a release date.
  • West-Ward has milrinone 1 mg/mL 10 mL vials on back order and the company estimates a release date of late-May to mid-June 2015. The 1 mg/mL 50 mL vials and 0.2 mg/mL 200 mL premix bags are on allocation. Milrinone 0.2 mg/mL 100 mL premix bags are on allocation with regular dating and with an expiration date of November 2015.

Related Shortages

Updated

May 19, April 15, 16, and 29, February 19, January 9, 16 and 30, 2015; December 1 and 18, November 5 and 14, October 2, September 10, August 1 and 14, July 2, 14, and 17, May 19 and 30, April 1, 16, and 30, March 7 and 11, February 3 and 14, January 21, 2014; December 12, November 15 and 26, October 3 and 24, September 12, August 14 and 26, July 3 and 9, June 20, May 8, April 1 and 19, February 7, 2013; December 12, November 7 and 15, October 2, September 14, July 9 and 26, June 4 and 21, May 9 and 25, April 6 and 27, March 2 and 22, February 1, 7 and 17, January 11 and 13, 2012; December 15 and 22, November 11, October 11, 18, and 27, September 22 and 23, August 26, July 29, June 29, May 23, April 8, 14 and 28, March 7 and 23, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement